U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Cancer biotherapy & radiopharmaceuticals

NLM Title Abbreviation:
Cancer Biother Radiopharm
Title(s):
Cancer biotherapy & radiopharmaceuticals.
Other Title(s):
Cancer biotherapy and radiopharmaceuticals
Merged From:
Cancer biotherapy ISSN 1062-8401
Antibody, immunoconjugates, and radiopharmaceuticals ISSN 0892-7049
Publication Start Year:
1996
Frequency:
Bimonthly
Country of Publication:
United States
Publisher:
Larchmont, NY : Mary Ann Liebert, Inc., c1996-
Description:
v. : ill., ports.
Language:
English
ISSN:
1084-9785 (Print)
1557-8852 (Electronic)
1084-9785 (Linking)
Coden:
CBRAFJ
LCCN:
sn 95005496
Electronic Links:
http://online.liebertpub.com/loi/cbr
In:
MEDLINE: v15n1, Feb. 2000-
PubMed: v15n1, Feb. 2000-
Index medicus
Current Indexing Status:
Currently indexed for MEDLINE.
Current Subset:
Index Medicus
MeSH:
Biological Products/therapeutic use*
Neoplasms/therapy*
Radioisotopes/therapeutic use*
Broad Subject Term(s):
Neoplasms
Pharmacology
Radiotherapy
Therapeutics
Publication Type(s):
Periodical
Notes:
Title from cover.
Also issued online.
Formed by the union of: Cancer biotherapy, and: Antibody, immunoconjugates, and radiopharmaceuticals, and continues the numbering of the former.
Other ID:
(DNLM)SR0086392(s)
(OCoLC)33232704
NLM ID:
9605408 [Serial]

Supplemental Content

Loading ...